Yan Guo, Donglu Shi, Hoonsung Cho, Zhongyun Dong, Amit Kulkarni, Gioanni Pauletti, Wei Wang, Jie Lian, Wen Liu, Lei Ren, Qiping Zhang, Guokui Liu, Christopher Huth, Lumin Wang, and Rodney Ewing; Advanced Functional Materials, DOI: 10.1002/adfm.200800406, August 2008.
Purpose of the Study:
Evalute the in vitro anti-cancer activity and in vivo imaging capabilities of a novel carbon nanotubule (CNT) functionalized with paclitaxel-loaded polymer and quantum dots (QD).
Methods:
The CNTs were coated with poly lactic-co-glycolic acid (PLGA), a biodegradable and FDA approved drug delivery polymer, by plasma polymerization in which monomers (acrylic acid, lactic acid, and glycolic acid) were introduced to the plasma reactor. HRTEM images reveal a PLGA film was deposited (~ 7nm thick) with an acrylic acid film on top (~ 3nm).
Amine-functionalized quantum dots were conjugated to the CNTs via a covalent bond between the amine group and carboxyl group in the acrylic acid film on the CNTs. HRTEM imaging and energy dispersive spectroscopy (EDS) confirmed conjugation. TEM imaging shows QDs were not evenly distributed – preferential conjugation of QD probably due to inhomogenous CNT dispersions). Fluorescence spectra shows emission wavelength of 73nm (shifted from 795nm with QD alone – mechanism not understood).
A well known chemotherapeutic agent, paclitaxel, was added by mixing PLGA-coated CNT with methanolic solution, evaporated, and then washed with distilled water.
Therapeutic efficacy was estimated in vitro by adding the QD-CNTs and free paclitaxel at varying doses to human PC-3MM2 prostate cancer cells and evaluating cell viability via MTT assay.
In vivo imaging capabilities were evaluated by injecting the QD-CNTs in the tail vein of mice and then pictures were taken with a Kodak 4000MM whole mouse imaging system at time intervals over 6 days.
Key Findings:
- HRTEM and EDS revealed that the novel CNT was fabricated as planned with a paclitaxel-loaded polymer and conjugated QDs.
- In vitro dose dependence curves indicate the QD-CNTs exhibited a five-fold increase in the loading capacity when the PLGA polymer is deposited on the CNTs versus no PLGA.
- The QD-CNTs had equivalent anti-cancer effects to free paclitaxel at a concentration of 100ng/ml.
- The QD’s emitted enough fluorescence for effective in vivo imaging. After six days, the QD-CNTs were concentrated in certain organ systems (particularly liver, kidney, stomach, and intestine.
Definitions:
MTT Assay – common assay performed to test cell viability.